GENFLEET-B 02595Hong Kong Stock Exchange

28.6001.56%( +0.440 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
GENFLEET-B (02595) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
GenFleet Therapeutics (Shanghai) Inc.
Market
HKEX Main Board
Listing Date
2025-09-19
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000074L2
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)152.76M85/112
Net Profit (Last FY)-2.10B121/125
ROE (Last FY)-98.89%106/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Qiang LU Executive Director
Jiong LAN Executive Director
ZHANG Wei Executive Director
ZHU Jingyang Non-Executive Director
TAO Sha Non-Executive Director
Christine Shaohua LU-WONG Independent Non-Executive Director
ZHOU Demin Independent Non-Executive Director
LI Bo Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-09-18.

About this page

This page shows GENFLEET-B (02595) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.